Home LiteratureArticle Details
PMID: 10714983 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition.

Journal of bacteriology ·Vol. 182 ·No. 7 ·2000-04-00 ·Pages 1802-11

Alland D, Steyn AJ, Weisbrod T, Aldrich K, Jacobs WR

Abstract

The cell wall provides an attractive target for antibiotics against Mycobacterium tuberculosis. Agents such as isoniazid and ethambutol that work by inhibiting cell wall biosynthesis are among the most highly effective antibiotics against this pathogen. Although considerable progress has been made identifying the targets for cell wall active antibiotics, little is known about the intracellular mechanisms that are activated as a consequence of cell wall injury. These mechanisms are likely to have an important role in growth regulation and in the induction of cell death by antibiotics. We previously discovered three isoniazid-induced genes (iniB, iniA, and iniC) organized in tandem on the M. tuberculosis genome. Here, we investigate the unique features of the putative iniBAC promoter. This promoter was specifically induced by a broad range of inhibitors of cell wall biosynthesis but was not inducible by other conditions that are toxic to mycobacteria via other mechanisms. Induction required inhibitory concentrations of antibiotics and could be detected only in actively growing cells. Analysis of the iniBAC promoter sequence revealed both a regulatory element upstream and a potential repressor binding region downstream of the transcriptional start site. The induction phenotype and structure of the iniBAC promoter suggest that a complex intracellular response occurs when cell wall biosynthesis is inhibited in M. tuberculosis and other mycobacteria.

MeSH Terms
Amino Acid Sequence Anti-Bacterial Agents/pharmacology Antitubercular Agents/pharmacology Base Sequence Binding Sites Cell Wall/drug effects,metabolism Gene Expression Regulation, Bacterial/drug effects Genes, Bacterial/genetics Isoniazid/pharmacology Kinetics Molecular Sequence Data Mycobacterium tuberculosis/cytology,drug effects,genetics,growth & development Operon/genetics Promoter Regions, Genetic/genetics RNA, Messenger/analysis,genetics Response Elements/genetics Sequence Deletion/genetics Species Specificity Transcription, Genetic/drug effects,genetics Transcriptional Activation/drug effects
Chemicals
Anti-Bacterial Agents Antitubercular Agents RNA, Messenger Isoniazid
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Alland D
Division of Infectious Diseases, Montefiore Medical Center, Bronx, New York 10467, USA. dalland404@aol.com
Steyn A J
Weisbrod T
Aldrich K
Jacobs W R
References (38)
38 references, click to expand
  1. Multiple antibiotic resistance in a bacterium with suppressed autolytic system.
    Nature. 1970 Jul 11;227(5254):138-40 PMID: 4393335
  2. Mycobacterial promoters.
    Tuber Lung Dis. 1997;78(5-6):211-23 PMID: 10209675
  3. Evidence for participation of autolysins in bactericidal action of oxacillin on Staphylococcus aureus.
    Antimicrob Agents Chemother. 1974 Dec;6(6):825-30 PMID: 4498775
  4. Tolerant response of Streptococcus sanguis to beta-lactams and other cell wall inhibitors.
    Antimicrob Agents Chemother. 1977 May;11(5):888-96 PMID: 879739
  5. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis.
    Mol Microbiol. 1990 Nov;4(11):1911-9 PMID: 2082148
  6. New use of BCG for recombinant vaccines.
    Nature. 1991 Jun 6;351(6326):456-60 PMID: 1904554
  7. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.
    J Bacteriol. 1992 Apr;174(8):2582-91 PMID: 1556077
  8. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection.
    Ann Intern Med. 1992 Aug 1;117(3):177-83 PMID: 1616211
  9. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis.
    Nature. 1992 Aug 13;358(6387):591-3 PMID: 1501713
  10. Estimates of future global tuberculosis morbidity and mortality.
    MMWR Morb Mortal Wkly Rep. 1993 Dec 17;42(49):961-4 PMID: 8246861
  11. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
    Science. 1994 Jan 14;263(5144):227-30 PMID: 8284673
  12. Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence.
    Infect Immun. 1994 Apr;62(4):1313-9 PMID: 8132338
  13. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods.
    N Engl J Med. 1994 Jun 16;330(24):1710-6 PMID: 7993412
  14. Induction of vancomycin resistance in Enterococcus faecium by non-glycopeptide antibiotics.
    FEMS Microbiol Lett. 1995 Oct 1;132(1-2):107-14 PMID: 7590155
  15. Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates.
    J Bacteriol. 1996 Jan;178(1):273-9 PMID: 8550428
  16. Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages.
    Infect Immun. 1996 May;64(5):1794-9 PMID: 8613393
  17. Biosynthesis of the linkage region of the mycobacterial cell wall.
    J Biol Chem. 1996 Mar 29;271(13):7820-8 PMID: 8631826
  18. Elements of signal transduction in Mycobacterium tuberculosis: in vitro phosphorylation and in vivo expression of the response regulator MtrA.
    J Bacteriol. 1996 Jun;178(11):3314-21 PMID: 8655513
  19. A study of mycobacterial transcriptional apparatus: identification of novel features in promoter elements.
    J Bacteriol. 1996 Aug;178(16):4847-53 PMID: 8759847
  20. Mycobacterium tuberculosis cell envelope.
    Curr Top Microbiol Immunol. 1996;215:1-27 PMID: 8791707
  21. Induction signals for vancomycin resistance encoded by the vanA gene cluster in Enterococcus faecium.
    Antimicrob Agents Chemother. 1996 Jul;40(7):1645-8 PMID: 8807055
  22. The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol.
    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11919-24 PMID: 8876238
  23. A vancomycin-inducible lacZ reporter system in Bacillus subtilis: induction by antibiotics that inhibit cell wall synthesis and by lysozyme.
    J Bacteriol. 1996 Nov;178(21):6305-9 PMID: 8892834
  24. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in gram-negative bacteria.
    Cell. 1997 Mar 21;88(6):823-32 PMID: 9118225
  25. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol.
    Nat Med. 1997 May;3(5):567-70 PMID: 9142129
  26. Determination of DNA sequences required for regulated Mycobacterium tuberculosis RecA expression in response to DNA-damaging agents suggests that two modes of regulation exist.
    J Bacteriol. 1997 Jun;179(11):3509-18 PMID: 9171394
  27. Biosynthesis of mycobacterial lipoarabinomannan.
    J Biol Chem. 1997 Jul 18;272(29):18460-6 PMID: 9218490
  28. The mycobacterial cell wall: biosynthesis of arabinogalactan and lipoarabinomannan.
    Biochem Soc Trans. 1997 Aug;25(3):845-50 PMID: 9388559
  29. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
    N Engl J Med. 1998 Jun 4;338(23):1641-9 PMID: 9614254
  30. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid.
    Science. 1998 Jun 5;280(5369):1607-10 PMID: 9616124
  31. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.
    Nature. 1998 Jun 11;393(6685):537-44 PMID: 9634230
  32. An antimicrobial activity of cytolytic T cells mediated by granulysin.
    Science. 1998 Oct 2;282(5386):121-5 PMID: 9756476
  33. Identification of differentially expressed mRNA in prokaryotic organisms by customized amplification libraries (DECAL): the effect of isoniazid on gene expression in Mycobacterium tuberculosis.
    Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13227-32 PMID: 9789070
  34. Transcription of two sigma 70 homologue genes, sigA and sigB, in stationary-phase Mycobacterium tuberculosis.
    J Bacteriol. 1999 Jan;181(2):469-76 PMID: 9882660
  35. Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization.
    Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12833-8 PMID: 10536008
  36. Exploring the new world of the genome with DNA microarrays.
    Nat Genet. 1999 Jan;21(1 Suppl):33-7 PMID: 9915498
  37. Exposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: implications for chemotherapy against mycobacterial persistors.
    Antimicrob Agents Chemother. 1999 Feb;43(2):218-25 PMID: 9925509
  38. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 1972 Jul;2(1):29-35 PMID: 4208567
Article Info
Journal
Journal of bacteriology
Abbr.
J Bacteriol
ISSN
0021-9193
Published
2000-04-00
Pages
1802-11
Language
English
Region
United States
NLM ID
2985120R
PMCID
PMC101861
Subset
IM
Grants
NIAID NIH HHS · N01 AI045244 · United States
NIAID NIH HHS · R01 AI043268 · United States
NIAID NIH HHS · R21 AI043268 · United States
NIAID NIH HHS · AI43268 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com